Literature DB >> 17086192

Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme.

Uhn Soo Cho1, Wenqing Xu.   

Abstract

Protein phosphatase 2A (PP2A) is a principal Ser/Thr phosphatase, the deregulation of which is associated with multiple human cancers, Alzheimer's disease and increased susceptibility to pathogen infections. How PP2A is structurally organized and functionally regulated remains unclear. Here we report the crystal structure of an AB'C heterotrimeric PP2A holoenzyme. The structure reveals that the HEAT repeats of the scaffold A subunit form a horseshoe-shaped fold, holding the catalytic C and regulatory B' subunits together on the same side. The regulatory B' subunit forms pseudo-HEAT repeats and interacts with the C subunit near the active site, thereby defining substrate specificity. The methylated carboxy-terminal tail of the C subunit interacts with a highly negatively charged region at the interface between A and B' subunits, suggesting that the C-terminal carboxyl methylation of the C subunit promotes B' subunit recruitment by neutralizing charge repulsion. Together, our structural results establish a crucial foundation for understanding PP2A assembly, substrate recruitment and regulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17086192     DOI: 10.1038/nature05351

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  196 in total

1.  HEAT repeat 1 motif is required for B56γ-containing protein phosphatase 2A (B56γ-PP2A) holoenzyme assembly and tumor-suppressive function.

Authors:  Yumiko Nobumori; Geoffrey P Shouse; Li Fan; Xuan Liu
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

2.  PP2A:B56{epsilon}, a substrate of caspase-3, regulates p53-dependent and p53-independent apoptosis during development.

Authors:  Zhigang Jin; Lindsay Wallace; Scott Q Harper; Jing Yang
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

Review 3.  Structural basis for protein phosphatase 1 regulation and specificity.

Authors:  Wolfgang Peti; Angus C Nairn; Rebecca Page
Journal:  FEBS J       Date:  2012-02-24       Impact factor: 5.542

4.  A case for "StopGo": reprogramming translation to augment codon meaning of GGN by promoting unconventional termination (Stop) after addition of glycine and then allowing continued translation (Go).

Authors:  John F Atkins; Norma M Wills; Gary Loughran; Chih-Yu Wu; Krishna Parsawar; Martin D Ryan; Chung-Hsiung Wang; Chad C Nelson
Journal:  RNA       Date:  2007-04-24       Impact factor: 4.942

5.  Scaling and self-organized criticality in proteins I.

Authors:  J C Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

6.  Posttranslational modifications of calcium/calmodulin-dependent protein kinase IIδ and its downstream signaling in human failing hearts.

Authors:  Tomas Rajtik; Eva Goncalvesova; Zoltan V Varga; Przemyslaw Leszek; Mariusz Kusmierczyk; Michal Hulman; Jan Kyselovic; Peter Ferdinandy; Adriana Adameova
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

7.  ELAS1-mediated inhibition of the cyclin G1-B'γ interaction promotes cancer cell apoptosis via stabilization and activation of p53.

Authors:  S Ohno; Y Naito; S Mukai; N Yabuta; H Nojima
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

8.  Molecular determinants for PP2A substrate specificity: charged residues mediate dephosphorylation of tyrosine hydroxylase by the PP2A/B' regulatory subunit.

Authors:  Amit Saraf; Elizabeth A Oberg; Stefan Strack
Journal:  Biochemistry       Date:  2010-02-09       Impact factor: 3.162

9.  PP2A-dependent disruption of centrosome replication and cytoskeleton organization in Drosophila by SV40 small tumor antigen.

Authors:  S Kotadia; L R Kao; S A Comerford; R T Jones; R E Hammer; T L Megraw
Journal:  Oncogene       Date:  2008-07-28       Impact factor: 9.867

10.  Crystal structures of protein phosphatase-1 bound to nodularin-R and tautomycin: a novel scaffold for structure-based drug design of serine/threonine phosphatase inhibitors.

Authors:  Matthew S Kelker; Rebecca Page; Wolfgang Peti
Journal:  J Mol Biol       Date:  2008-11-01       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.